Navigation Links
Skin Appendage Tumors Seem on the Rise in U.S.
Date:6/21/2010

Cancer of sweat glands most common, but cases of eyelid cancer also up, study finds

MONDAY, June 21 (HealthDay News) -- Tumors of skin appendages, such as sweat glands, mammary glands, hair and nails, appear to be increasing in the United States, says a new study.

Because these cutaneous appendageal carcinomas are still rare, research into them has been limited.

In this new study, a team at the U.S. National Cancer Institute analyzed 1978 to 2005 data from 16 cancer registries and found that the incidence rate for these types of cancers was 5.1 cases per 1 million people. Men were more likely than women to develop one of the cancers. Whites had higher rates than Hispanics, blacks and Asian/Pacific Islanders. The most common type was cancer of the sweat glands (apocrine-eccrine carcinoma).

Incidence rates of cutaneous appendageal cancers increased with age. People 80 and older were 100 times more likely to develop one of these cancers than people aged 20 to 29.

The researchers also found that rates of cutaneous appendageal cancers increased 150 percent between the periods 1978 to 1982 and 2002 to 2005. Rates of sweat gland cancer increased 170 percent and rates of cancers of the eyelid glands (sebaceous carcinomas) increased 217 percent.

Five-year survival rates for cutaneous appendageal cancers were 99 percent for localized disease and 43 percent for cancers that had spread to other parts of the body.

The study is published in the June issue of the Archives of Dermatology.

"Cutaneous appendageal carcinoma incidence rates are increasing in the United States, especially for sebaceous carcinoma, perhaps related to improved recognition and classification, but factors such as UV exposure and immunosuppression may also play a role," Patrick W. Blake and colleagues said in a news release from the publisher. "Further increases in cutaneous appendageal carcinomas over time should prompt new strategies for cancer screening and early intervention of this cancer."

More information

The American Society of Clinical Oncology has more about eyelid cancer.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, June 21, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Taking aim at metastatic lung tumors
2. Drug that restricts blood supply to prostate tumors delays disease progression
3. Delay in surgery not likely to worsen tumors in men with low-risk prostate cancer
4. FDA approves first human neural stem cell clinical trial to treat brain tumors
5. Detecting tumors faster
6. Drug that helps metastatic colon cancer of no benefit in less advanced tumors
7. Black Men at Greater Risk of Aggressive Prostate Tumors: Study
8. Childhood Brain Tumors May Respond to Measles Virus
9. A new cancer vaccine starves tumors of blood
10. ASCO data highlight novel anti-cancer approach that exposes tumors to immune attack
11. Drug now used to treat erectile dysfuncton may enhance delivery of herceptin to certain brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Skin Appendage Tumors Seem on the Rise in U.S. 
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology: